The BC Innovation Council (BCIC), a crown agency of the Province of BC, focused on driving BC’s economic engine through the advancement of BC tech and market-driven innovation, announced that University of British Columbia (UBC) Life Sciences Institute (LSI) Director Dr. Pieter Cullis, was one of the first four recipients of its Ignite Awards.
Cullis is working with Integrated Nanotherapeutics, Dr. Marcel Bally (BC Cancer Agency), Dr. Marco Ciufolini (UBC Chemistry) and Dr. Lorne Whitehead (UBC Physics) in developing a new nanoparticle system that can be triggered by X-ray to release anti-cancer drugs at a tumour.
The project and the other three recipients met award criteria and demonstrate the ability to adapt and succeed in fields as diverse as electrochemistry, biotech, mining and structural engineering. Award criteria is based on commercial and technical viability as well as the ability to be market ready within three years. Applicants must be partnered with industry and academia for matching of funds and delivery of market-driven research.
As a result of the unique BCIC Ignite model, more than $2.7M is being contributed to the four projects to commercialize transformative research. BCIC Ignite not only requires research to be market ready within a three-year time frame but also leverages its funds through a consortium of industry and academia that matches funds, $2 per each $1 BCIC Ignite.
“BC is home to transformative research that can solve problems for markets around the world,” said Shirley Vickers, President and CEO, BC Innovation Council. “BCIC Ignite accelerates the commercialization of groundbreaking research to change BC and change the world.”